The risk that research and development may stall or become difficult to continue due to the progress of joint R&D counterparties, cost-sharing arrangements, renewal or termination of agreements, or changes in research structures resulting from organizational reorganizations or M&A. This covers dependence on joint R&D partners generally, not only on specific universities.